Winters Chad 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Winters Chad
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2024-03-11−675→ 896 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (675 underlying) - Exercise/Conversion
Common Stock
2024-03-11$173.22/sh+675$116,924→ 2,123.698 total - Sale
Common Stock
2024-03-11$358.82/sh−815$292,436→ 1,308.698 total
Footnotes (1)
- [F1]2021 PSUs (PP20) award vesting net of taxes withheld.